BackSumitomo Pharma , Ltd. Overview

Sumitomo Pharma , Ltd. Current Cash

Latest current cash for SMDPY: $78B.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$77.76B
↑ 98.85% YoYΔ $38.65B vs prior year quarter

Peer trimmed avg / median

Loading

Sumitomo Pharma , Ltd. Current Cash History

Loading

Sumitomo Pharma , Ltd. vs. peers: Current Cash Comparison

Loading

Sumitomo Pharma , Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sumitomo Pharma , Ltd. (SMDPY) FAQ

The latest current cash for SMDPY is $78B as of September 2026. That compares with $39B in the prior-year period — up 98.8% year over year. Investors often review this figure alongside Sumitomo Pharma , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SMDPY's current cash moved from $39B to $78B — a 98.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sumitomo Pharma , Ltd.'s operating scale or balance-sheet position.

A current cash figure of $78B for SMDPY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SMDPY's current cash ($78B), review year-over-year change from $39B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.